{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:45:11Z","timestamp":1793051111422,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772994"],"award-info":[{"award-number":["81772994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2022QH1150"],"award-info":[{"award-number":["2022QH1150"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J011296"],"award-info":[{"award-number":["2023J011296"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejphar.2025.178372","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:22:35Z","timestamp":1763324555000},"page":"178372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Selection and validation of a cell-internalizing DNA aptamer targeting esophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"1008","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-7022","authenticated-orcid":false,"given":"Kunrong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuancan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178372_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02039-w","article-title":"Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors","volume":"40","author":"Agnello","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178372_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","article-title":"Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Ajani","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw. : J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ejphar.2025.178372_bib3","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1039\/D1MD00199J","article-title":"Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents","volume":"12","author":"Alamudi","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178372_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.talanta.2018.10.063","article-title":"In vitro selection of CD70 binding aptamer and its application in a biosensor design for sensitive detection of SKOV-3 ovarian cells","volume":"194","author":"Bayat","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.ejphar.2025.178372_bib5","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1021\/jp112059y","article-title":"Physics-based de novo prediction of RNA 3D structures","volume":"115","author":"Cao","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2025.178372_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041273","article-title":"An aptamer against MNK1 for non-small cell lung cancer treatment","volume":"15","author":"Carri\u00f3n-Marchante","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2025.178372_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5030049","article-title":"Aptamer cell-based selection: overview and advances","volume":"5","author":"Catuogno","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.178372_bib8","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1039\/D1AN00634G","article-title":"Evolution of DNA aptamers against esophageal squamous cell carcinoma using cell-SELEX","volume":"146","author":"Chen","year":"2021","journal-title":"The Analyst"},{"key":"10.1016\/j.ejphar.2025.178372_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2018.03.021","article-title":"Selection of specific aptamer against enrofloxacin and fabrication of graphene oxide based label-free fluorescent assay","volume":"549","author":"Dolati","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2025.178372_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cgh.2018.07.018","article-title":"Underuse of surgery accounts for racial disparities in esophageal cancer survival times: a matched cohort study","volume":"17","author":"Dong","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178372_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178372_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omtn.2018.11.011","article-title":"Genetic alphabet expansion provides versatile specificities and activities of unnatural-base DNA aptamers targeting cancer cells. Molecular therapy","volume":"14","author":"Futami","year":"2019","journal-title":"Nucleic acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib13","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1007\/s00253-016-7686-2","article-title":"Cell-targeting aptamers act as intracellular delivery vehicles","volume":"100","author":"Gopinath","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejphar.2025.178372_bib14","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/jacs.9b10510","article-title":"Molecularly engineering triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast cancer","volume":"142","author":"He","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2025.178372_bib15","doi-asserted-by":"crossref","first-page":"23299","DOI":"10.1002\/anie.202107347","article-title":"Aptamer-PROTAC conjugates (APCs) for tumor-specific targeting in breast cancer","volume":"60","author":"He","year":"2021","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejphar.2025.178372_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jjco\/hyz034","article-title":"Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy","volume":"49","author":"Hirano","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.178372_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-019-1955-7","article-title":"Development of a novel ssDNA aptamer targeting neutrophil gelatinase-associated lipocalin and its application in clinical trials","volume":"17","author":"Hong","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.178372_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10388-023-01033-9","article-title":"Association between continuous cessation or reduction of drinking alcohol and improvement of multiple dysplastic lesions in patients with esophageal squamous cell carcinoma after endoscopic resection","volume":"21","author":"Hori","year":"2024","journal-title":"Esophagus : Offic. J. Esophageal Society"},{"key":"10.1016\/j.ejphar.2025.178372_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.73","article-title":"Targeting insulin receptor with a novel internalizing aptamer","volume":"5","author":"Iaboni","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib20","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178372_bib21","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1159\/000495925","article-title":"Characterization of a DNA aptamer for ovarian cancer clinical tissue recognition and in vivo imaging","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.ejphar.2025.178372_bib22","doi-asserted-by":"crossref","first-page":"20755","DOI":"10.1021\/acsomega.0c01132","article-title":"The combination of two bioactive constituents, lactoferrin and linolenic acid, inhibits mouse xenograft esophageal tumor growth by downregulating lithocholyltaurine and inhibiting the JAK2\/STAT3-Related pathway","volume":"5","author":"Li","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2025.178372_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00604-023-05828-6","article-title":"Highly sensitive and specific resonance rayleigh scattering detection of esophageal cancer cells via dual-aptamer target binding strategy","volume":"190","author":"Li","year":"2023","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.ejphar.2025.178372_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12951-021-01135-5","article-title":"Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2025.178372_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40364-023-00510-8","article-title":"The application of Aptamer in biomarker discovery","volume":"11","author":"Li","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ejphar.2025.178372_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115239","article-title":"Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release","volume":"207","author":"Liu","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2025.178372_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.stem.2013.01.007","article-title":"Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells","volume":"12","author":"Liu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2025.178372_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ymthe.2020.01.012","article-title":"Targeting SOX2 protein with peptide aptamers for therapeutic gains against esophageal squamous cell carcinoma","volume":"28","author":"Liu","year":"2020","journal-title":"Mol. Ther. : J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.ejphar.2025.178372_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep18516","article-title":"Using aptamers to elucidate esophageal cancer clinical samples","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178372_bib30","article-title":"Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178372_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/mt.2011.277","article-title":"A general RNA motif for cellular transfection","volume":"20","author":"Magalhaes","year":"2012","journal-title":"Mol. Ther. : J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.ejphar.2025.178372_bib32","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1007\/s00253-023-12765-0","article-title":"Aptamer-based technology for detecting Bacillus subtilis in soil","volume":"107","author":"Manfredini","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejphar.2025.178372_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20660-3","article-title":"Development and characterization of DNA aptamer against retinoblastoma by Cell-SELEX","volume":"12","author":"Maradani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178372_bib34","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/nprot.2010.163","article-title":"Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures","volume":"5","author":"Mayer","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2025.178372_bib35","article-title":"Ligand-installed nanocarriers toward precision therapy","volume":"32","author":"Mi","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejphar.2025.178372_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2019.01.045","article-title":"Aptamer-functionalized liposomes for targeted cancer therapy","volume":"448","author":"Moosavian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.178372_bib37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1053\/j.gastro.2015.08.054","article-title":"Recent advances from basic and clinical studies of esophageal squamous cell carcinoma","volume":"149","author":"Ohashi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178372_bib38","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1016\/j.biomaterials.2013.07.099","article-title":"Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer","volume":"34","author":"Parekh","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2025.178372_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060814","article-title":"In vivo evaluation of (68)Ga-Labeled NOTA-EGFRvIII aptamer in EGFRvIII-Positive glioblastoma xenografted model","volume":"16","author":"Park","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2025.178372_bib40","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1039\/D4NR05114A","article-title":"Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC)","volume":"17","author":"Peng","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejphar.2025.178372_bib41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.omtn.2023.08.015","article-title":"Targeting triple-negative breast cancer cells with a \u03b21-integrin binding aptamer","volume":"33","author":"Pleiko","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtn.2017.06.018","article-title":"In vitro selection of cell-internalizing DNA aptamers in a model system of inflammatory kidney disease","volume":"8","author":"Ranches","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtn.2017.06.018","article-title":"In vitro selection of cell-internalizing DNA aptamers in a model system of inflammatory kidney disease","volume":"8","author":"Ranches","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.talanta.2018.01.083","article-title":"Development and characterization of DNA aptamers against florfenicol: fabrication of a sensitive fluorescent aptasensor for specific detection of florfenicol in milk","volume":"182","author":"Sadeghi","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.ejphar.2025.178372_bib45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nprot.2010.66","article-title":"Development of DNA aptamers using Cell-SELEX","volume":"5","author":"Sefah","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2025.178372_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaoncol.2018.5441","article-title":"Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE-180 study","volume":"5","author":"Shah","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejphar.2025.178372_bib47","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1073\/pnas.0602615103","article-title":"Aptamers evolved from live cells as effective molecular probes for cancer study","volume":"103","author":"Shangguan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178372_bib48","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/bioinformatics\/btn328","article-title":"iFoldRNA: three-dimensional RNA structure prediction and folding","volume":"24","author":"Sharma","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2025.178372_bib49","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/acsnano.2c07488","article-title":"Identifying TOPK and hypoxia hallmarks in esophageal tumors for photodynamic\/chemo\/immunotherapy and liver metastasis inhibition with nanocarriers","volume":"17","author":"Shi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2025.178372_bib50","article-title":"Screening of single-stranded DNA aptamer specific for florfenicol and application in detection of food safety","volume":"12","author":"Shi","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.ejphar.2025.178372_bib51","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3748\/wjg.v30.i19.2496","article-title":"Immunotherapy for esophageal cancer: where are we now and where can we go","volume":"30","author":"Shoji","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.178372_bib52","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.34458","article-title":"The contribution of smoking and smokeless tobacco to oesophageal squamous cell carcinoma risk in the African oesophageal cancer corridor: results from the ESCCAPE multicentre case-control studies","volume":"152","author":"Simba","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.178372_bib53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.omtn.2020.11.016","article-title":"Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide","volume":"23","author":"Tanaka","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5030051","article-title":"Toward the selection of cell targeting aptamers with extended biological functionalities to facilitate endosomal escape of cargoes","volume":"5","author":"Tawiah","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.178372_bib55","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1093\/nar\/gks294","article-title":"Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers","volume":"40","author":"Thiel","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178372_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043836","article-title":"Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection","volume":"7","author":"Thiel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178372_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4939-1538-5_11","article-title":"Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells","volume":"1218","author":"Thiel","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178372_bib58","first-page":"432","article-title":"Global burden and epidemiology of barrett oesophagus and oesophageal cancer. Nature reviews","volume":"18","author":"Thrift","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178372_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178372_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17425247.2019.1575808","article-title":"An exploration of aptamer internalization mechanisms and their applications in drug delivery","volume":"16","author":"Wan","year":"2019","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejphar.2025.178372_bib61","doi-asserted-by":"crossref","first-page":"16923","DOI":"10.1021\/acsnano.3c04002","article-title":"Photoactivated DNA nanodrugs damage mitochondria to improve gene therapy for reversing chemoresistance","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2025.178372_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115646","article-title":"From cell-SELEX to tissue-SELEX for targeted drug delivery and aptamer nanomedicine","volume":"224","author":"Wong","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2025.178372_bib63","doi-asserted-by":"crossref","first-page":"985","DOI":"10.7150\/thno.11938","article-title":"DNA aptamer selected against pancreatic ductal adenocarcinoma for in vivo imaging and clinical tissue recognition","volume":"5","author":"Wu","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2025.178372_bib64","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-024-01973-3","article-title":"Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178372_bib65","article-title":"Development of a specific aptamer-modified nano-system to treat esophageal squamous cell carcinoma","volume":"11","author":"Xie","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2025.178372_bib66","article-title":"Vfold: a web server for RNA structure and folding thermodynamics prediction","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178372_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-62703-730-3_18","article-title":"Cell internalization SELEX: in vitro selection for molecules that internalize into cells","volume":"1103","author":"Yan","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178372_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00323-3","article-title":"Advances in targeted therapy for esophageal cancer","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178372_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125902","article-title":"Aptamer-drug conjugates (ApDCs): transformative approaches in targeted cancer therapy and precision oncology","volume":"681","author":"Zahedi","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2025.178372_bib70","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.omtn.2022.02.006","article-title":"Transferrin receptor-mediated internalization and intracellular fate of conjugates of a DNA aptamer. Molecular therapy","volume":"27","author":"Zhang","year":"2022","journal-title":"Nucleic acids"},{"key":"10.1016\/j.ejphar.2025.178372_bib71","article-title":"Development of bivalent Aptamer-DNA carrier-doxorubicin conjugates for targeted killing of esophageal squamous cell carcinoma cells","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178372_bib72","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ymthe.2022.02.018","article-title":"Nucleic acid aptamer controls mycoplasma infection for inhibiting the malignancy of esophageal squamous cell carcinoma","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2025.178372_bib73","article-title":"Screening and identification of novel DNA aptamer for targeted delivery to injured podocytes in glomerular diseases","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2025.178372_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1454114","article-title":"Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report","volume":"15","author":"Zhu","year":"2024","journal-title":"Front. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:51:05Z","timestamp":1773802265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"alternative-id":["S0014299925011264"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178372","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection and validation of a cell-internalizing DNA aptamer targeting esophageal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178372"}}